Finance

Senarai
1ZTS:BIT
Zoetis Inc
€61.60
-0.93%
(-0.58) 1H
2 Okt, 5:26:00 PTG GMT+2  ·   EUR
Semua simbol
SimbolHargaPerubahan% Perubahan
Menjana cerapan popular untuk 1ZTS...
Buka
€61.60
Tinggi
€61.60
Rendah
€61.60
Permodalan Pasaran
28.80B
Purata volum
384.00
Volum
8.00
tgi 52 mgu
€130.06
rdh 52 mgu
€61.04
Bilangan pekerja
14K
Buka
€61.60
Tinggi
€61.60
Rendah
€61.60
Permodalan Pasaran
28.80B
Purata volum
384.00
Volum
8.00
tgi 52 mgu
€130.06
rdh 52 mgu
€61.04
Bilangan pekerja
14K
Cerita berita
Daripada sumber web dan rakan kongsi berita
Profil
Zoetis Inc., headquartered in Parsippany, New Jersey, is the largest producer of medicine and vaccinations for pets and livestock worldwide. The company's products include antiparasitics, vaccines, products that relieve itch, anti-infectives, products that alleviate pain, animal health diagnostics, as well as hormones, cardiopulmonary, topical and oral hygiene therapeutics, central nervous system drugs, diuretics, antiemetic, euthanasia, and hepato-digestive products. The company has operations in over 50 countries. In 2025, 70% of the company's revenue came from products for pets and 29% of the company's revenues came from products for livestock. In 2025, 54% of the company's revenue came from customers in the United States. Of this revenue, 79% came from products for dogs and cats, 13% came from products for cattle, and 4% came from products for horses. In 2025, 46% of the company's revenue came from international customers. Of this revenue, 53% came from products for dogs and cats, 19% came from products for cattle, 9% came from products for swine, 7% came from products for poultry, and 3% came from products for horses. Wikipedia
Perihal Zoetis Inc
CEOKristin C. Peck
Pekerja14.5K
Diasaskan1952
Ibu pejabatParsippany-Troy Hills, New Jersey, Amerika Syarikat
Sektor-
Laman webzoetis.com
Laporan sebelumnyaSemua nilai dalam USD
Loading Previous Earnings...
Hasil
Pendapatan bersih
Semua nilai dalam USD
Sep 2025
Dis 2025
Mac 2026
Jun 2026
Hasil
2.40B
2.39B
2.26B
2.47B
Kos barangan yang dijual
682.00J
711.00J
640.00J
670.00J
Kos hasil
682.00J
711.00J
640.00J
670.00J
Perbelanjaan penyelidikan dan pembangunan
170.00J
199.00J
180.00J
173.00J
Jumlah perbelanjaan penyelidikan dan pembangunan
-
-
-
-
Perbelanjaan jualan, am dan pentadbiran
572.00J
618.00J
584.00J
589.00J
Belanja kendalian
774.00J
848.00J
795.00J
793.00J
Jumlah belanja kendalian
1.46B
1.56B
1.44B
1.46B
Pendapatan kendalian
944.00J
828.00J
827.00J
1.00B
Pendapatan bukan kendalian lain
-
-6.00J
-1.00J
-2.00J
EBT termasuk item luar biasa
887.00J
761.00J
758.00J
866.00J
EBT tidak termasuk item luar biasa
899.00J
780.00J
779.00J
948.00J
Belanja cukai pendapatan
166.00J
158.00J
157.00J
175.00J
Kadar cukai berkesan
18.71%
20.76%
20.71%
20.21%
Belanja kendalian lain
-
-
-
-
Pendapatan bersih
721.00J
603.00J
601.00J
691.00J
Margin untung bersih
30.04%
25.26%
26.57%
28.00%
Perolehan bagi setiap syer
1.70
1.48
1.53
1.87
Pendapatan faedah dan pelaburan
26.00J
25.00J
21.00J
16.00J
Belanja faedah
-58.00J
-57.00J
-62.00J
-61.00J
Belanja faedah bersih
-32.00J
-32.00J
-41.00J
-45.00J
Caj susut nilai dan pelunasan
-
-
-
-
EBITDA
1.07B
903.00J
946.00J
1.12B
Keuntungan atau kerugian daripada jualan aset
-
-
-6.00J
-1.00J
Kandungan AI boleh mengandungi kesilapan. Ketahui lebih lanjut
BantuanHantar maklum balasPrivasiSyaratPenafian
Apl Google